Literature DB >> 30062561

Lateral rectus muscle recession for intermittent exotropia with anomalous head position in type 1 Duane's retraction syndrome.

Ju-Yeun Lee1, Kyung-Ah Park1, Sei Yeul Oh2.   

Abstract

BACKGROUND: We questioned how to treat for intermittent exotropia in type 1 Duane's retraction syndrome (DRS). To avoid secondary abduction deficit and late overcorrection on the affected eye following ipsilateral lateral rectus (LR) recession, we performed less correction of the lateral rectus (LR) recession to correct exodeviation and anomalous head position (AHP). We report the surgical outcomes of LR recession in patients with unilateral type 1 DRS.
METHODS: Four patients who underwent less correction of LR recession in the affected eye to correct intermittent exotropia and AHP to the contralateral side in type 1 DRS were enrolled. Data on preoperative and postoperative angle of exodeviation, degree of AHP, ocular motility, global retraction, palpebral fissure change, and complications were retrospectively obtained. Success was defined as postoperative deviation within 8 prism diopters (PD) and AHP < 5°.
RESULTS: The preoperative angles of exodeviation and AHP were significantly improved after LR recession. The median grade of abduction limitation was improved from - 1.3 to - 0.8 postoperatively. Final median value of deviation was orthotropia in the primary position of the eye with the normal motility. All patients had successful outcomes without overcorrection or further abduction limitation in DRS eyes.
CONCLUSIONS: Less correction of ipsilateral LR recession may be useful for correcting intermittent exotropia and AHP in patients with type 1 DRS.

Entities:  

Keywords:  Duane retraction syndrome; Intermittent exotropia; Lateral rectus recession; Modified grading

Mesh:

Year:  2018        PMID: 30062561     DOI: 10.1007/s00417-018-4079-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Results of bilateral medial rectus muscle recession in unilateral esotropic Duane syndrome.

Authors:  Majid Farvardin; Abbas Hoseini Rad; Abdolsamad Ashrafzadeh
Journal:  J AAPOS       Date:  2009-08       Impact factor: 1.220

2.  Correction of discrete subaortic stenosis with abnormal chordae tendineae.

Authors:  Valerio Mazzei; Giuseppe Nasso; Amedeo Anselmi; Giovanni Salamone; Santi Mangano; Rosario Grassi
Journal:  J Card Surg       Date:  2006 May-Jun       Impact factor: 1.620

3.  Electrophysiology of the retraction syndromes.

Authors:  A Huber
Journal:  Br J Ophthalmol       Date:  1974-03       Impact factor: 4.638

4.  Surgical treatment of Duane's syndrome.

Authors:  S H Pressman; W E Scott
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

5.  The usefulness of the cervical range of motion device in the ocular motility examination.

Authors:  B J Kushner
Journal:  Arch Ophthalmol       Date:  2000-07

6.  The efficacy of asymmetric bilateral medial rectus muscle recession surgery in unilateral, esotropic, type 1 Duane syndrome.

Authors:  Gad Dotan; Ainat Klein; Noa Ela-Dalman; Shiri Shulman; Chaim Stolovitch
Journal:  J AAPOS       Date:  2012-12       Impact factor: 1.220

7.  Vertical muscle transposition augmented with lateral fixation (Foster) suture for Duane syndrome and sixth nerve palsy.

Authors:  S Akar; B Gokyigit; G Pekel; A Demircan; A Demirok
Journal:  Eye (Lond)       Date:  2013-08-02       Impact factor: 3.775

8.  Improvement of compensatory head postures after strabismus surgery.

Authors:  S P Kraft; E P O'Donoghue; J D Roarty
Journal:  Ophthalmology       Date:  1992-08       Impact factor: 12.079

9.  Vertical rectus muscle transposition surgery for Duane's syndrome.

Authors:  A B Molarte; A L Rosenbaum
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1990 Jul-Aug       Impact factor: 1.402

10.  Clinical features of Duane's syndrome.

Authors:  E L Raab
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1986 Mar-Apr       Impact factor: 1.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.